Sort
64,565 grants matching “drug discovery”
ALCOHOL DEPENDENCE IN AFRICAN AMERICANS: A CASE-CONTROL GENETIC STUDY
$668,070Richard A Grucza · Washington University · R01 · FY2012 · AA
Protein Tyrosine Dephosphorylation & signal Transduction
$668,025Nicholas K Tonks · Cold Spring Harbor Laboratory · R37 · FY2008 · CA
Influence of Opioids on the Brainstem Respiratory Network
$667,991Donald C Bolser · University Of Florida · R01 · FY2024 · HL
Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct Locations
$667,987Charles Darkoh · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · AI
Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct Locations
$667,987Charles Darkoh · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · AI
Lewy body dementia pathway and biomarker discovery
$667,958Lih-Shen Chin · Emory University · R56 · FY2020 · AG
Clinically Translatable MRI Reporter Genes and Imaging Methods with Ultra-High Specificity and Sensitivity
$667,932Christian T Farrar · Massachusetts General Hospital · R01 · FY2025 · EB
Addressing Hepatitis C and Hepatocellular Carcinoma: Current and Future Epidemics
$667,893Holly C. Hagan · New York University · R01 · FY2015 · DA
Clinical Development of Novel Drugs for Children with Refractory Cancers
$667,799Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Direct targeting of HIF1a-driven transcription in TNBC with engineered STRs
$667,792Raymond E Moellering · University Of Chicago · R01 · FY2025 · CA
Direct targeting of HIF1a-driven transcription in TNBC with engineered STRs
$667,792Raymond E Moellering · University Of Chicago · R01 · FY2024 · CA
Cell-free assay technologies for the identification of active compounds
$667,741Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Utilizing IgG Autoantibodies As Biomarkers In IgA Nephropathy
$667,669Janusz Tucholski · Reliant Glycosciences Llc · R44 · FY2022 · DK
Inhaled Stressors and Lung Aging
$667,664Corrine R Kliment · University Of Pittsburgh At Pittsburgh · R61 · FY2025 · AG
Structural, mechanistic, & evolutionary characterization of tetracycline destructases
$667,614Gautam Dantas · Washington University · U01 · FY2021 · AI
Development of therapeutic GABA-producing bacteria
$667,602Philip Peter Strandwitz · Holobiome, Inc. · R44 · FY2021 · DK
Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma
$667,561Anne Josephine Novak · Mayo Clinic Rochester · R01 · FY2017 · CA
Expanding the Chemical Diversity of Therapeutic Oligonucleotides
$667,550Anastasia Khvorova · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · NS
TWEAK-Fn14 regulation of non-canonical NF-kB signaling in chronic renal inflammation
$667,500Michael A. Ortega · Queen'S Medical Center · R21 · FY2023 · DK
NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis
$667,474Alex A Adjei · Mayo Clinic Rochester · UM1 · FY2019 · CA
Protozoan Population Genetics and Inflammation
$667,382Michael Grigg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Decode polyadenylation in health and disease
$667,379Yongsheng Shi · University Of California-Irvine · R01 · FY2025 · CA
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease
$667,269Rima F Kaddurah-Daouk · Duke University · R01 · FY2024 · AG
Developmental Funds Core
$667,250Andrew K Godwin · University Of Kansas Medical Center · P30 · FY2023 · CA
Selective disruption of histone deacetylase complexes using protein interaction modulators
$667,246Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2023 · CA